cvs xkhtm cvs united states securities and exchange commission washington dc form annual report pursuant section dof securities exchange act for fiscal year ended december or transition report pursuant section dof securities exchange act for transition period commission file number cvs caremark corporation exact name registrant specified charter delaware state jurisdiction incorporation organization irs employer identification no one cvs drive woonsocket rhode island address principal executive offices zip code registrants telephone number including area code securities registered pursuant sectionbof exchange act common stock par value per share new york stock exchange title class name exchange registered securities registered pursuant sectiongof exchange act none indicate check mark registrant well known seasoned issuer defined rule securities actyes no indicate check mark registrant required file reports pursuant section sectiondof actyes no indicate check mark whether registrant filed reports required filed section dof securities exchange act preceding months shorter period registrant required file reports subject filing requirements past daysyes no indicate check mark whether registrant submitted electronically posted corporate website every interactive data file required submitted posted pursuant rule regulation preceding months shorter period registrant required submit post filesyes no indicate check mark disclosure delinquent filers pursuant item regulation contained herein contained best registrants knowledge definitive proxy information statements incorporated reference partiii form amendment form indicate check mark whether registrant large accelerated filer accelerated filer non accelerated filer smaller reporting company see definition large accelerated filer accelerated filer smaller reporting company ruleb exchange act largeacceleratedfiler accelerated filer non accelerated filer do check smaller reporting company smaller reporting company indicate check mark whether registrant shell company defined ruleb actyes no the aggregate market value registrants common stock held non affiliates approximately june based closing price common stock new york stock exchange for purposes calculation executive officers directors deemed affiliates registrant as february registrant shares common stock issued outstanding documents incorporated by reference filings made companies securities exchange commission sometimes incorporate information reference this means company referring information previously filed filed sec information considered part filing reading the following materials incorporated reference form portions annual report stockholders fiscal year ended december incorporated reference response items partii information contained proxy statement annual meeting stockholders incorporated reference response items partiii table of contents page parti item business itema risk factors itemb unresolved staff comments item properties item legal proceedings item mine safety disclosures executive officers registrant partii item market registrants common equity related stockholder matters issuer purchases equity securities item selected financial data item managements discussion analysis financial condition results operations itema quantitative qualitative disclosures about market risk item financial statements supplementary data item changes disagreements accountants accounting financial disclosure itema controls procedures itemb other information partiii item directors executive officers corporate governance item executive compensation item security ownership certain beneficial owners management related stockholder matters item certain relationships related transactions director independence item principal accountant fees services partiv item exhibits financial statement schedules signatures parti item business overview cvs caremark corporation cvs caremark company us together subsidiaries largest integrated pharmacy health care provider united states we uniquely positioned deliver significant benefits health plan sponsors effective cost management solutions innovative programs engage plan members promote healthier cost effective behaviors our integrated pharmacy services model enhances ability offer plan members consumers expanded choice greater access personalized services help path better health we effectively manage pharmaceutical costs improve health care outcomes pharmacy benefit management pbm mail order specialty pharmacy division cvs caremark pharmacy services cvspharmacy longs drugs drogaria onofre retail stores retail based health clinic subsidiary minuteclinic online retail pharmacies cvscom onofrecombr we currently three reportable segments pharmacy services retail pharmacy corporate pharmacy services segment the pharmacy services segment provides full range pbm services described fully clients consisting primarily employers insurance companies unions government employee groups managed care organizations mcos sponsors health benefit plans individuals throughout united states in addition silverscript insurance company silverscript subsidiary national provider drug benefits eligible beneficiaries federal governments medicare partd program the pharmacy services segment operates cvs caremark pharmacy services caremark cvs caremark careplus cvspharmacy rxamerica accordant silverscript novologix names as december pharmacy services segment operated retail specialty pharmacy stores specialty mail order pharmacies four mail service dispensing pharmacies located states puerto rico district columbia pharmacy services business strategy our business strategy centers providing innovative pharmaceutical solutions quality client service order enhance clinical outcomes clients health benefit plan members assisting clients plan members better managingoverall health care costsour goal produce superior results clients plan membersby leveragingour expertise core pbm services includingplan design administration formulary management discounted drug purchase arrangements medicare partd services mail order specialty pharmacy infusion services retail pharmacy network management services prescription management systems clinical services disease management services medical spend management in addition fully integrated pharmacy services company able offer clients plan members variety programs plan designs benefit integrated information systems ability pharmacists nurse practitioners physician assistants interact personally many plan members shop stores every daythrough multiple member touch points retail stores mail order specialty pharmacies retail clinics call centers proprietary websites mobile devices seek engage plan members behaviors lower cost improve health care outcomesexamples programs services include maintenance choice program eligible client plan members elect fill maintenance prescriptions retail pharmacy stores price mail order pharmacy advisor program facilitates face face telephone counseling pharmacists help participating plan members certain chronic diseases diabetes cardiovascular conditions identify gaps care adhere prescribed medications manage health conditions compliance persistency programs designed ensure patients take medications proper manner enhanced disease management programs targeted managing chronic disease states extracare health card program offers discounts eligible plan members certain counter health care products sold cvspharmacy storesin addition minuteclinic important differentiated part enterprise capabilities available pbm members ways working clients include partnerships health plan clients sponsoring patient centered medical homes biometric screening opportunities closing gaps care co pay reductions encourage use minuteclinic onsite clinics client corporate headquarters pbm services our pbm services described fully plan design administration our clients sponsor pharmacy benefit plans facilitate ability eligible members plans receive prescribed medications we assist clients designing pharmacy benefit plans minimize costs client prioritizing welfare safety clients members we also administer benefit plans clients assist monitoring effectiveness plans frequent informal communications well formal annual client review we make recommendations clients encouraging design benefit plans promoting use lowest cost clinically appropriate drug we help clients control costs recommending plan designs encourage use generic equivalents brand name drugs equivalents available our clients also option plan design lower pharmacy benefit plan costs setting different member payment levels different products drug lists formulary management we utilize independent panel doctors pharmacists medical experts referred pharmacy therapeutics committee select drugs meet highest standards safety efficacy inclusion drug lists our drug lists provide recommended products numerous drug classes ensure member access clinically appropriate alternatives clients pharmacy benefit plan to improve clinical outcomes members clients conduct ongoing independent reviews drugs including limited appearing drug lists generic equivalent products well clinical programs many clients choose adopt drug lists part plan design discounted drug purchase arrangements we negotiate pharmaceutical companies obtain discounted acquisition costs many products drug lists negotiated discounts enable us offer reduced costs clients choose adopt drug lists the discounted drug purchase arrangements negotiate typically provide volume discounts andor payment pharmaceutical companies retroactive discounts rebates established list prices for certain products purchased pharmacies receive discounts time purchase andor discounts prompt payment invoices we also receive various purchase discounts wholesale contracts may include retroactive discounts rebates exceed contractually defined purchase volumes we record discounts regardless form reduction cost revenues medicare partd services we participate administration drug benefit added medicare program partd medicare prescription drugimprovement modernization act medicare partd provision pbm services health plan clients clients qualified medicare partd prescription drug plans pdp we also participate iby offering medicare partd pharmacy benefits subsidiary silverscript approved pdp centers medicare medicaid services cms iiby assisting employer union health plan clients qualify retiree drug subsidy available medicare partd collecting submitting eligibility andor drug cost data cms order obtain subsidy mail order pharmacy as december operated four mail service dispensing pharmacies united states plan members prescribers submit prescriptions refill requests primarily maintenance medications pharmacies via mail telephone fax prescribing internet we also operate network smaller mail service specialty pharmacies described our staff pharmacists review mail service prescriptions refill requests assistance prescription management systems this review may involve communications prescriber prescribers approval result generic substitution therapeutic interchange actions designed reduce cost improve quality treatment these pharmacies awarded mail service pharmacy accreditation utilization review accreditation commission urac washington dc based health care accrediting organization establishes quality standards health care industry specialty pharmacy our specialty pharmacies support individuals require complex expensive drug therapies as december specialty pharmacies comprised specialty mail order pharmacies located throughout united states used delivery advanced medications individuals chronic genetic diseases disorders substantially pharmacies accredited joint commission independent profit organization accredits certifies health care organizations programs united states these pharmacies also awarded specialty pharmacy accreditation urac as december company operated network retail specialty pharmacy stores operate careplus cvspharmacy name these stores average square feet size sell prescription drugs limited assortment front store items alternative medications homeopathic remedies vitamins in january enhanced offerings specialty infusion services began offering enteral nutrition services subsidiary coram llc coram acquired january coram one nation largest providers comprehensive infusion services caring approximately patients annually retail pharmacy network management we maintain national network nearly retail pharmacies consisting approximately chain pharmacies includes cvspharmacy stores independent pharmacies united states including puerto rico district columbia when customer fills prescription retail pharmacy pharmacy sends prescription data electronically us point sale this data interfaces proprietary prescription management systems verify relevant plan member data eligibility also performing drug utilization review evaluate clinical appropriateness safety confirming pharmacy receive payment prescription prescription management systems we dispense prescription drugs directly one mail service specialty pharmacies network retail pharmacies all prescriptions whether filled one mail service dispensing pharmacies pharmacy retail network analyzed processed documented proprietary prescription management systems these systems assist staff network pharmacists processing prescriptions automating review various items including limited plan eligibility early refills duplicate dispensing appropriateness dosage drug interactions allergies utilization potential fraud clinical services we offer multiple clinical programs services help clients manage overall pharmacy health care costs clinically appropriate manner our programs primarily designed promote safety target inappropriate utilization non adherence medication may result adverse medical events negatively impact member health client pharmacy medical spend in regard offer various utilization management medication management quality assurance adherence counseling programs complement clients plan design clinical strategies disease management programs our clinical services utilize advanced protocols offer clients convenience working health care providers third parties our accordant programs include integrated rare disease management programs cover diseases rheumatoid arthritis parkinsons disease seizure disorders multiple sclerosis the majority integrated programs accredited national committee quality assurance private profit organization evaluates accredits certifies wide range health care organizations they also awarded case management accreditation urac medical pharmacy management we offer technology platform helps identify capture cost savings opportunities specialty drugs billed medical benefit helps ensure appropriate clinical use drugs pharmacy services information systems we currently operate several adjudication platforms support pharmacy services segment the information systems incorporate architecture centralizes data generated filling mail service prescriptions adjudicating retail pharmacy claims fulfilling services provide pbm clients pharmacy services clients our clients primarily sponsors health benefit plans employers insurance companies unions government employee groups mcos individuals located throughout united states we provide pharmaceuticals eligible members benefit plans maintained clients utilize information systems among things perform safety checks drug interaction screening generic substitution we generate substantially pharmacy services segment net revenue dispensing prescription drugs eligible members benefit plans maintained clients no single pbm client accounted total consolidated revenues our client agreements subject renegotiation terms see risk factors efforts reduce reimbursement levels alter health care financing practices risk factors risks declining gross margins pbm industry during year ended december pbm filled managed approximately million prescriptions pharmacy services seasonality the majority pharmacy services segment revenues seasonal nature pharmacy services competition we believe primary competitive factors industry include ithe ability negotiate favorable discounts drug manufacturers iithe ability negotiate favorable discounts access retail pharmacy networks iiiresponsiveness clients needs ivthe ability identify apply effective cost management programs utilizing clinical strategies vthe ability develop utilize preferred drug lists vithe ability market pbm products services viithe commitment provide flexible clinically oriented services clients viiithe quality scope costs products services offered clients members the pharmacy services segment significant number competitors offering pbm services eg express scripts optumrx catamaran prime therapeutics including large national pbm companies pbms owned large national health plans smaller standalone pbms retail pharmacy segment as december retail pharmacy segment included retail drugstores operated pharmacy online retail pharmacy websites cvscom onofrecombr onsite pharmacy stores retail health care clinics the retail drugstores located states district columbia puerto rico brazil operating primarily cvspharmacy longs drugs drogaria onofre names we currently operate top us drugstore markets hold number one number two market share markets cvspharmacy stores sell prescription drugs wide assortment counter personal care products beauty cosmetic products general merchandise refer front store products existing retail stores range size approximately square feet although new stores range size approximately square feet typically include drive thru pharmacy during filled million retail prescriptions approximately us retail pharmacy market as december operated retail health care clinics states district columbia minuteclinic name located within cvspharmacy stores retail pharmacy business strategy our integrated pharmacy services model enhanced ability retail pharmacy stores expand customer access care helping lower overall health care costs improve health outcomes in regard role retail pharmacist shifting primarily dispensing prescriptions also providing services including flu vaccinations well face face patient counseling respect adherence drug therapies closing gaps care cost effective drug therapies in addition personalization core retail strategy we number initiatives underway extracare weekly individually tailored circular acts personal shopper customer designed help us connect directly individual consumers deliver personalized experience we also provide broad assortment quality merchandise competitive prices using retail format emphasizes service innovation convenience one keys strategy technology allows us focus constantly improving service exploring ways provide personalized product offerings services we believe continuing first market new unique products services using innovative marketing adjusting mix merchandise match customers needs preferences important ability continue improve customer satisfaction retail pharmacy products services typical cvspharmacy store sells prescription drugs wide assortment high quality nationally advertised brand name proprietary brand merchandise front store categories include counter drugs beauty products cosmetics photo finishing services seasonal merchandise greeting cards convenience foods we purchase merchandise numerous manufacturers distributors we believe competitive sources readily available substantially products carry loss one supplier would likely material effect business retail pharmacy segment net revenues major product group follows percentageofnetrevenues prescription drugs over counter personal care beautycosmetics general merchandise percentages estimates based store point sale pos data pharmacy pharmacy revenues represented two thirds retail pharmacy revenues we believe pharmacy operations continue represent critical part business due favorable industry trends eg aging american population consuming greater number prescription drugs pharmaceuticals used often first line defense managing illness impact expanded health insurance coverage affordable care act introduction new pharmaceutical products medicare partd ongoing program purchasing customer lists independent pharmacies we believe pharmacy business benefits investment people technology given nature prescriptions people want prescriptions filled accurately professional pharmacists using latest tools technology ready promised consumers need medication management programs better information help get health care dollars to assist customers needs introduced integrated pharmacy health care services provide earlier easier effective approach engaging behaviors help lower costs improve health save lives examples include patient care initiative enhanced medication adherence program maintenance choice program eligible client plan members elect fill maintenance prescriptions retail pharmacy stores price mail order pharmacy advisor program facilitates pharmacist counseling face face telephone help participating plan members certain chronic diseases diabetes cardiovascular conditions identify gaps care adhere prescribed medications manage health conditions further evidencing belief importance pharmacy service continuing investment technology drug utilization review system checks harmful interactions prescription drugs counter products vitamins herbal remedies pharmacy fulfillment system rx connect prescription refill program readyfill online business cvscom front store front store revenues benefited strategy first market new unique products services using innovative marketing adjusting mix merchandise match customers needs preferences key component front store strategy extracare card program helping us continue build loyal customer base the extracare program one largest successful retail loyalty programs united states in addition extracare program allows us balance marketing efforts reward best customers providing automatic sale prices customized coupons extrabucks rewards benefits another component front store strategy unique product offerings include full range high quality cvspharmacy proprietary brand products available cvspharmacy stores we currently carry cvspharmacy proprietary brand products accounted approximately front store revenues furthermore tailoring certain groups stores urban cluster stores better meet needs customers minuteclinic as december operated minuteclinic locations states district columbia located cvspharmacy storesminuteclinics staffed nurse practitioners physician assistants utilize nationally recognized protocols diagnose treat minor health conditions perform health screenings monitor chronic conditions deliver vaccinationsmany locations also begun treating variety chronic conditionsinsurers value minuteclinic provides convenient high quality cost effective care many cases offering attractive alternative expensive sites careas result visits paid employers health insurers third parties accounted approximately minuteclinics total revenues we anticipate opening approximately new clinics cvspharmacy stores minuteclinic collaborating pharmacy services segment help meet needs cvs caremarks client plan members offering programs improve member health lower costs minuteclinic affiliated major health systems onsite pharmacies we also operate limited number small pharmacies located client sites careplus cvspharmacy cvspharmacy name provide certain health plan members customers convenient alternative filling prescriptions retail pharmacy store development the addition new stores played continue play major role continued growth success our store development program focuses three areas entering new markets adding stores within existing markets relocating stores convenient freestanding sites during opened new retail pharmacy stores relocated stores closed stores during last five years opened new relocated stores acquired stores during expect square footage growth we believe continuing grow store base locating stores desirable geographic markets essential components compete effectively current health care environment as result believe store development program integral part ability maintain leadership position retail drugstore industry retail pharmacy information systems we continued invest information systems enable us deliver exceptional customer service enhance safety quality expand patient care services lowering operating costs in completed rollout proprietary wecare workflow retail pharmacy locations wecare workflow integrated suite enhancements rxconnect fulfillment system pharmacy pos terminals phone system support pharmacy colleagues customers seamlessly integrating prioritizing prescription fulfillment prescriber contact management customer service actions patient care interventions cohesive workflow in near term solution delivers improved efficiency enhances customer experience longer term solution provides framework accommodate evolution pharmacy practice expansion clinical programs our consumer engagement engine technology proprietary clinical algorithms enable us identify opportunities pharmacists deliver face face counseling regarding patient health safety matters including adherence issues gaps care management certain chronic health conditions our digital strategy empowers consumer navigate pharmacy experience manage condition line mobile tools offer utility convenience cvscom gained new look added new tools access world class drug information personalization pharmacy services we experienced strong adoption digital solutions mobile app receiving critical acclaim ease use text message program experiencing unprecedented growth retail pharmacy customers managed care organizations government funded health care programs including state medicaid plans medicare partd drug plans commercial employers third party plans accounted pharmacy revenues the loss one payor material effect business no single retail payor accounts total consolidated revenues however success retail drugstore business dependent upon ability establish maintain contractual relationships pbms payors acceptable terms our contracts commercial payors government funded programs subject renegotiation reimbursement rates see government regulation reimbursement itema risk factors efforts reduce reimbursement levels alter health care financing practices retail pharmacy seasonality the majority revenues particularly pharmacy revenues generally seasonal nature however front store revenues tend higher decemberholiday season for additional information refer note quarterly financial information annual report stockholders year ended december section incorporated reference herein retail pharmacy competition the retail drugstore business highly competitive we believe compete principally basis istore location convenience iicustomer service satisfaction iiiproduct selection variety ivprice in markets serve compete drugstore chains supermarkets discount retailers independent pharmacies membership clubsinternet companies retail health clinics well mail order pharmacies pbms corporate segment our corporate segment provides management administrative services support overall operations company the corporate segment consists certain aspects executive management corporate relations legal compliance human resources corporate information technology finance departments generic sourcing venture in december announced signing agreement cardinal health inc cardinal health form generic pharmaceutical sourcing entity this entity expected operational soon july initial term ten years under arrangement companies contributing sourcing supply chain expertise entity committing source negotiate generic pharmaceutical supply contracts cvs caremark cardinal health entity working capital practices we fund growth business combination cash flow operations commercial paper proceeds sale leaseback transactions long term borrowings for additional information working capital practices refer caption liquidity capital resources annual report stockholders year ended december section incorporated reference herein the majority non pharmacy revenues paid cash debit credit cards managed care third party insurance programs typically settle less days represented approximately consolidated pharmacy revenues including retail pharmacy pharmacy services combined the remainder consolidated pharmacy revenues paid cash debit credit cards our customer returns significant colleague development as december employed approximately colleagues included pharmacists nurse practitioners physician assistants the total included approximately part time colleagues work less hours per week to deliver highest levels service customers devote considerable time attention people service standards we emphasize attracting training knowledgeable friendly helpful associates work organization intellectual property we registered andor applied register variety trademarks service marks used throughout business well domain names rely combination copyright patent trademark trade secret laws addition contractual restrictions establish protect proprietary rights we regard intellectual property significant value pharmacy services retail pharmacy segments we aware facts could materially impact continuing use intellectual property government regulation overview our business subject federal state laws regulations govern purchase sale distribution prescription drugs related services including administration management prescription drug benefits many pbm clients payors retail pharmacy segment including insurers mcos subject extensive regulations affect design implementation prescription drug benefit plans sponsor the application complex legal regulatory requirements detailed operation business creates areas uncertainty particularly following enactment medicare modernization act mma patient protection affordable care act health care education reconciliation act collectively aca significant legal regulatory developments past years in addition mma aca numerous proposed health care laws regulations federal state levels could adversely affect business enacted we unable predict federal state legislation regulatory initiatives may enacted future relating business health care industry general effect legislation regulations might business any failure alleged failure comply applicable laws regulations summarized adverse applications changes laws regulations affecting business could material adverse effect operating results andor financial condition anti remuneration laws federal law prohibits among things entity knowingly willfully offering paying soliciting receiving subject certain exceptions safe harbors remuneration induce referral individuals purchase lease order arranging recommending purchase lease order items services payment may made medicare medicaid certain federal health care programs number states similar laws limited services paid government funds state laws exceptions safe harbors vary infrequently interpreted courts regulatory agencies sanctions violating federal state anti remuneration laws may include imprisonment criminal civil fines exclusion participation medicare medicaid government sponsored health care programs the federal anti remuneration law interpreted broadly courts office inspector general oig within united states department health human services hhs administrative bodies see item legal proceedings information antitrust unfair competition the federal trade commission ftc authority section federal trade commission act ftca investigate prosecute practices unfair trade practices unfair methods competition numerous lawsuits filed throughout united states pharmaceutical manufacturers retail pharmacies andor pbms various state federal antitrust unfair competition laws challenging among things ibrand drug pricing practices pharmaceutical manufacturers iithe maintenance retail pharmacy networks pbms iiivarious business practices pbms retail pharmacies to extent appear actual potential market power relevant market business arrangements uses confidential information may subject heightened scrutiny anti competitive perspective possible challenge state federal regulators private parties see item legal proceedings information consumer protection laws the federal government many consumer protection laws ftca federal postal service act ftc telemarketing sales rule most states also similar consumer protection laws these laws basis investigations lawsuits multi state settlements relating among matters marketing loyalty programs health care services pricing accuracy expired front store products financial incentives provided drug manufacturers pharmacies connection therapeutic interchange programs contract audits we subject audits many contracts including pbm client contracts pbm rebate contracts contracts relating medicare partd agreement pharmacies enter payors because contracts state federal governments entities contracted state federal agencies audits agreements often regulated federal state agencies responsible administering federal state benefits programs including operate medicaid fee service plans managed medicaid plans medicare partd plans medicare advantage organizations disease management services regulation we provide disease management programs pbm plan members rare medical conditions arrange receive disease management programs common medical conditions state laws regulate practice medicine practice pharmacy practice nursing clinicians engaged professional practice connection provision disease management services must satisfy applicable state licensing requirements environmental regulation our business subject various federal state local laws regulations requirements pertaining protection environment public health including example regulations governing management waste materials waste waters governmental agencies federal state local levels recent years increasingly focused retail sectors compliance laws regulations times pursued enforcement activities erisa regulation the employee retirement income security act amended erisa provides comprehensive federal regulation certain employee pension benefit plans including private employer union sponsored health plans certain plans contract us provide pbm services in general assist plan sponsors administration prescription drug portion health benefit plans accordance plan designs adopted plan sponsors we believe conduct business subjects us fiduciary obligations erisa except specifically contracted plan sponsor accept limited fiduciary responsibility adjudication initial prescription drug benefit claims andor appeals denied claims plan respect contraceptive coverage mandate one health reforms included aca we pbms named lawsuits alleging act fiduciary term defined erisa respect health benefit plans breached certain fiduciary obligations erisa in addition fiduciary provisions erisa imposes civil criminal liability service providers health plans certain persons certain forms illegal remuneration made received these provisions erisa similar identical health care anti remuneration statutes discussed although erisa lacks statutory regulatory safe harbor exceptions incorporated health care statutes similar health care statutes corresponding provisions erisa broadly written application specific business practices often uncertain state laws discussed government regulation section may applicable us plan sponsors customers may preempted whole part erisa however scope erisa preemption uncertain subject conflicting court rulings false claims fraudulent billing statutes range federal civil criminal laws target false claims fraudulent billing activities one significant laws federal false claims act fca prohibits submission false claim making false record statement order secure reimbursement limit reimbursement government sponsored program the fraud enforcement recovery act fera implemented substantial changes fca expands scope fca liability provides new investigative tools makes easier qui tam relators often referred whistleblowers bring maintain fca suits behalf government aca eased burden whistleblowers bring maintain fca suits modifying public disclosure original source provisions fca most states passed substantially similar acts in recent years federal state government authorities launched several initiatives aimed uncovering practices violate false claims fraudulent billing laws conducted numerous investigations pharmaceutical manufacturers pbms pharmacies health care providers respect false claims fraudulent billing related matters see item legal proceedings information fda regulation the united states food drug administration fda generally authority regulate drugs drug classifications drug promotional information materials disseminated drug manufacturer persons behalf drug manufacturer the fda also regulatory authority many products sold retail pharmacies including certain food items cosmetics dietary supplements counter otc medications ii require submission implementation risk evaluation mitigation strategy rems fda determines rems necessary safe effective marketing drug to extent dispense products subject rems requirements provide rems services pharmaceutical manufacturers subject audit fda pharmaceutical manufacturer the fda also regulatory authority medical devices otc genetic tests genetic tests conducted medical laboratories fda continues evaluate need regulation tests federal employee health benefits program we contractual arrangement bluecross blueshield association bcbsa provide pharmacy services federal employees postal workers annuitants dependents government wide service benefit plan authorized federal employees health benefits act fehba part federal employees health benefits program fehbpthis arrangement subjects us fehba federal regulations federal employees health benefits acquisition regulation otherwise applicable us formulary regulation number states regulate administration prescription drug benefits additionally national association insurance commissioners naic developed model law health carriers prescription drug benefit management model act addresses formulary regulation issues risk bearing entities regulated state insurance commissioners could form basis state legislation medicare part regulates formularies developed administered including requiring inclusion drugs certain classes categories subject limited exceptions medicare part plan formulary aca essential health benefits rule also imposes minimum drug coverage requirement health plans subject requirements including plans offered federal state exchanges the increasing government regulation formularies could significantly affect ability develop administer formularies behalf insurer mco clients government agreements mandates in march company entered settlement agreement federal government number states related dispensing generic drug ranitidine retail pharmacies at time company entered corporate integrity agreement oig period five years applicable certain retail mail service operations company this corporate integrity agreement requires among things maintenance compliance program employee training specific reviews independent review organization various government reporting obligations in april entered amendment corporate integrity agreement connection previously announced settlement federal state government investigation certain retail pharmacy billing practices respect dual eligible customers medicaid coverage third party insurance coverage this amendment requires company comply corporate integrity agreement amended period three years requires among things additional employee training obligations additional reporting obligations periodic medicaid billing reviews independent review organization failure meet obligations corporate integrity agreement amended could result stipulated financial penalties failure comply material terms could lead exclusion applicable business participation federal health care programs in january entered separate settlement agreements ftc hhs office civil rights ocr resolving joint investigation disposal patient information limited number cvspharmacy locations as part ftc settlement agreed maintain appropriate enterprise wide information security program twenty year term agreement biennial compliance monitoring external assessor as part ocr settlement agreed maintain confidential waste disposal policies procedures training employee sanctions retail stores the ocr settlement provided annual compliance monitoring external assessor in june received ocr closure letter noted material compliance ocr settlement agreement significantly improved retail store processes surrounding protected health information mandatory monitoring reporting obligations satisfied in october company entered non prosecution agreement civil settlement agreement us department justice doj various united states attorneys offices relating sale distribution pseudoephedrine products certain cvspharmacy stores primarily california nevada the company also entered related memorandum agreement us drug enforcement administration dea the non prosecution agreement memorandum agreement contain certain ongoing compliance requirements company failure comply terms documents could lead civil criminal remedies financial penalties andor administrative remedies dea registrations retail pharmacies distribution centers the term non prosecution agreement three years ended october the term memorandum agreement five years in may previously announced proposed consent order ftc company became final concluded ftc investigation company commenced the final consent order prohibits company misrepresenting price cost medicare partd prescription drugs prices costs associated medicare partd prescription drug plans on october dea administrator published final decision order revoking dea license registrations dispensing controlled substances two retail pharmacy stores sanford florida the license revocations two stores formally became effective november the pharmacies voluntarily suspended dispensing controlled substances since april continued operating manner compliance dea order in addition government agreements described company andor various affiliates subject consent decrees settlement agreements various federal state local authorities may contain certain ongoing reporting monitoring compliance requirements company these agreements relate matters privacy practices waste disposal practices selling expired products environmental safety matters tobacco sales marketing advertising practices pharmacy operations various business practices health reform legislation congress passed major health reform legislation referred document aca this legislation affects virtually every aspect health care country in addition establishing framework every individual health coverage beginning aca enacted number significant health care reforms while reforms affect business directly many affect coverage plan designs provided many health plan clients as result reforms could indirectly impact many services business practices many cases directly impact services business practices given many regulations implementing aca still finalized ongoing sub regulatory guidance still issued considerable uncertainty full impact company managed care reform in addition health reforms enacted aca proposed legislation considered state level legislation enacted several states aimed primarily providing additional rights access drugs individuals enrolled managed care plans this legislation may impact design implementation prescription drug benefit plans sponsored pbm health plan clients andor services provide both scope managed care reform proposals considered state legislatures reforms enacted states date vary greatly scope future legislation may enacted uncertain medicare partd the medicare part program makes prescription drug coverage available eligible medicare beneficiaries private insurers regulates aspects provision medicare drug coverage including enrollment formularies pharmacy networks marketing claims processing the medicare partd program undergone significant legislative regulatory changes since inception including changes made aca in april cms issued rule requires coverage basic prescription drug coverage offered medicare part employer group waiver plans egwps included definition health prescription drug coverage starting january cms clarified supplemental benefits primarily reduce cost sharing claims covered basic benefit continue practical matter subject medicare part rules medicare partd continues attract high degree legislative regulatory scrutiny applicable government rulesand regulations continue evolve cms sanctions non compliance may include suspension enrollment even termination program cms imposed restrictions consent requirements automatic prescription delivery programs limited circumstances medicare part plans may recoup payments pharmacies claims subsequently determined payable medicare part expected issue proposed regulation may limit ability medicare part plans establish preferred pharmacy networks accordingly possible legislative regulatory developments regulatory oversight could materially affect medicare partd business profitability network access legislation majority states form legislation affecting ability limit access pharmacy provider network remove network providers certain willing provider legislation may require us clients admit non participating pharmacy pharmacy willing able meet plans price applicable terms conditions network participation these laws vary significantly state state regard scope requirements application to extent state federal willing provider laws determined apply us certain clients pharmacy networks manage pbm clients laws could negatively impact services economic benefits achievable limited pharmacy provider network pbm laws regulation legislation seeking regulate pbm activities comprehensive manner introduced enacted number states this legislation varies scope often contains provisions may impact company to extent states government entities enact legislation regulating pbms survive legal challenges enforceability legislation could adversely impact ability conduct business commercially reasonable terms locations legislation effect in addition certain quasi regulatory organizations including national association boards pharmacy naic issued model regulations may propose future regulations concerning pbms andor pbm activities similarly credentialing organizations national committee quality assurance urac may establish voluntary standards regarding pbm specialty pharmacy activities while actions quasi regulatory standard setting organizations force law may influence states adopt requirements recommendations influence client requirements pbm specialty pharmacy services moreover standards established organizations could also impact health plan clients andor services provide pharmacy professional licensure regulation we subject state federal statutes regulations governing operation retail mail pharmacies transfer prescriptions repackaging drug products wholesale distribution dispensing controlled substance listed chemical products medical controlled substance waste disposal federal state statutes regulations govern labeling packaging advertising adulteration prescription drugs dispensing controlled substances state regulations require compliance standards established united states pharmacopeia respect packaging storing shipping pharmaceuticals federal state controlled substance laws require us register pharmacies distribution centers dea state controlled substances agencies comply security recordkeeping inventory control personnel labeling standards order possess dispense controlled substances listed chemical products we undergo audits regulatory bodies regular basis plan design legislation some states enacted legislation prohibits health plan sponsor implementing certain restrictive design features many states introduced legislation regulate various aspects managed care plans including provisions relating pharmacy benefits legislation imposing plan design mandates may apply certain clients could effect limiting economic benefits achievable pbm services provide privacy confidentiality requirements many activities involve receipt use disclosure us personally identifiable information pii permitted accordance applicable federal state privacy data security laws require organizations provide appropriate privacy protections security safeguards information in addition pii use disclose de identified data analytical purposes the federal health insurance portability accountability act regulations issued thereunder collectively hipaa impose extensive requirements way health plans health care providers health care clearinghouses known covered entities business associates use disclose safeguard protected health information phi hipaa also gives individuals certain rights respect phi for uses disclosures phi treatment payment health care operations certain public policy purposes hipaa generally requires covered entities obtain individuals written authorization criminal penalties civil sanctions may imposed failing comply hipaa standards in january hhs issued rule implementing health information technology economic clinical health act hitech act enacted part american recovery reinvestment act among things therule expands circumstances authorizations required send communications individuals funded third parties extends hipaa privacy security requirements penalties directly business associates covered entities in addition hipaa states enacted health care information confidentiality laws limit disclosure confidential medical information these state laws supersede hipaa extent protective individual privacy hipaa hhs also issued regulations requiring federal state exchanges impose privacy security standards non exchange entities protect pii obtained exchanges beginning in proposed regulations hhs defined term non exchange entities include insurers offering plans exchanges would require entities turn impose stringent privacy security standards downstream entities if rule finalized proposed unless hipaa covered entities able negotiate exchange accept compliance hipaa privacy security standards substitute complying exchange privacy security standards insurers offering plans exchanges business associates could potentially subject additional privacy security standards addition hipaa existing stringent state laws reimbursement significant portion net revenue derived directly medicare medicaid government sponsored health care programs therefore subject among laws regulations federal state reimbursement laws regulatory requirements anti remuneration laws stark law andor federal state false claims laws see self referral laws section explanation stark law sanctions violating federal andor state laws may include without limitation recoupment reduction government reimbursement amounts criminal civil penalties exclusion participation medicare medicaid government health care programs see item legal proceedings information changes reporting average wholesale price awp average manufacturer price amp average sales price pricing elements common payment formulas adjustments may made regarding reimbursement drug payments medicaid medicare could impact pricing customers payors andor could impact ability negotiate discounts rebates manufacturers wholesalers pbms retail mail pharmacies in circumstances changes could also impact reimbursement receive medicare medicaid programs drugs covered programs mcos contract government health programs provide prescription drug benefits reimportation the mma amended food drug cosmetic act providing fda promulgate rulesthat would permit pharmacists wholesalers import prescription drugs canada united states certain circumstances however promulgation rulesis subject precondition fda certify congress reimportation would pose additional risk publics health safety would result significant cost reduction to date fda provided certification the fda continues strongly oppose efforts allow widespread importation drugs canada elsewhere citing concerns activities undermine fdas ability oversee quality safety nations drug supply if fda changes position permits broader importation drugs canada future new pending health legislation regulations permit importation drugs european union countries future pharmacy services could impacted retail clinics states regulate retail clinics operated nurse practitioners physician assistants physician oversight lab licensing prohibition corporate practice medicine number states implemented proposed laws regulations impact certain components retail clinic operations physician oversight signage third party contracting requirements bathroom facilities scope services these laws regulations may affect operation expansion owned managedretail clinics safety regulations the occupational safety health act amended osha establishes certain employer responsibilities including maintenance workplace free recognized hazards likely cause death serious injury compliance standards promulgated osha various record keeping reporting procedural requirements many osha standards well various state local laws regulations pertaining employee safety health including apply specifically healthcare employees apply operations any failure comply regulations could result fines sanctions government authorities self referral laws the federal law commonly known stark law prohibits physician referring medicare medicaid beneficiaries designated health services include among things outpatient prescription drugs home health services durable medical equipment supplies entity physician immediate family member physician financial relationship prohibits entity receiving prohibited referral presenting claim medicare medicaid designated health service furnished prohibited referral state statutes regulations also prohibit payments referral individuals physicians health care providers physicians financial relationship some state statutes regulations apply services reimbursed governmental well private payors violation laws may result prohibition payment services rendered loss pharmacy health care provider licenses fines criminal penalties the laws exceptions safe harbors may vary federal stark law vary significantly state state the laws often vague many cases interpreted courts regulatory agencies state insurance laws pdps pbm service contracts including assume certain risk performance guarantees similar arrangements generally subject insurance regulation states however pbm offers provide prescription drug coverage capitated basis otherwise accepts material financial risk providing pharmacy benefits laws regulations various states may applicable such laws may require party risk become licensed insurer establish reserves otherwise demonstrate financial viability laws may apply cases include insurance laws laws governing mcos limited prepaid health service plans the company offers pdp silverscript subject state insurance laws regarding licensure solvency some states laws prohibit submitting false claim making false record statement order secure reimbursement insurance company these state laws vary violation may lead imposition civil criminal penalties additionally several states passed legislation governing prompt payment claims requires among things health plans payors pay claims within certain prescribed time periods pay specified interest penalties these laws vary state state regard scope requirements application clear extent may apply clients us certain health plans payors may exempt laws basis erisa preemption scope erisa preemption unclear telemarketing other outbound contacts certain federal state laws telephone consumer protection act tcpa give ftc federal communications commission fcc state attorneys general law enforcement tools regulate telemarketing practices certain automated outbound contacts phone calls texts emails these laws may among things impose registration requirements require disclosures specific information prohibit misrepresentations limit consumers may contacted require consumer consent prior contacted require transmission caller id information prohibit certain abandoned outbound calls prohibit unauthorized billing set payment restrictions sale certain goods services require establishment certain policies training personnel require retention specific business records in october new fcc rules went effect aimed better aligning fccs regulatory response tcpa ftcs response well requiring written prior consent calls using automatic telephone dialing system call mobile number artificial prerecorded voice call residential mobile number the companys use telemarketing outbound contacts could impacted laws regulations third party administration other state licensure laws many states licensure registration laws governing certain types administrative organizations preferred provider organizations third party administrators companies provide utilization review services several states also licensure registration laws governing organizations provide administer consumer card programs also known cash card discount card programs the scope laws differs significantly state state application laws activities often unclear whistleblower statutes certain federal state laws including fca contain provisions permitting filing qui tam whistleblower lawsuits alleging violations laws whistleblower provisions allow private individuals bring lawsuits behalf federal state government alleging defendant defrauded government generally minimum evidentiary legal threshold required bringing lawsuit these lawsuits typically filed seal applicable federal state enforcement authority authority required review allegations made determine whether intervene lawsuit take lead litigation because qui tam lawsuit typically filed seal pending government review allegations defendant generally may aware lawsuit government determines whether intervene lawsuit otherwise unsealed process may take years see item legal proceedings information although believe material compliance existing laws regulations applicable various business lines cannot give assurances business financial condition results operations materially adversely affected required materially change business practices based ifuture enactment new health care laws regulations iithe interpretation application existing laws regulations including laws regulations described government regulation section may relate business pharmacy services retail pharmacy retail clinic industry health care industry generally iiipending future federal state governmental investigations business pharmacy services retail pharmacy retail clinic industry health care industry generally ivinstitution government enforcement actions us vadverse developments pending qui tam lawsuit us whether sealed unsealed future qui tam lawsuit may filed us viadverse developments pending future legal proceedings us affecting pharmacy services retail pharmacy retail clinic industry health care industry generally available information cvs caremark corporation delaware corporation our corporate office located one cvs drive woonsocket rhode island telephone our common stock listed new york stock exchange trading symbol cvs general information cvs caremark available companys web site httpinfocvscaremarkcom our financial press releases filings us securities exchange commission sec available free charge within investors section web site httpwwwcvscaremarkcominvestors in addition sec maintains internet site contains reports proxy information statements information regarding issuers company file electronically sec the address web site httpwwwsecgov itema risk factors our business subject various industry economic regulatory risks uncertainties our business financial condition results operations cash flows prospects could materially adversely affected one following risk factors additional risks uncertainties presently known us currently deem immaterial the health economy general markets serve our business affected economy general including changes consumer purchasing power preferences andor spending patterns although economic recovery might underway possible worsening economic environment cause decline drug utilization dampen demand pharmacy benefit management services well consumer demand products sold retail stores further interest rate fluctuations changes capital market conditions regulatory changes may affect ability obtain necessary financing acceptable terms ability secure suitable store locations acceptable terms ability execute sale leaseback transactions acceptable terms these circumstances could result adverse effect business financial results efforts reduce reimbursement levels alter health care financing practices the continued efforts health maintenance organizations managed care organizations pbm companies government entities third party payors reduce prescription drug costs pharmacy reimbursement rates may impact profitability in particular increased utilization generic pharmaceuticals normally yield higher gross profit rate equivalent brand named drugs resulted pressure decrease reimbursement payments retail mail order pharmacies generic drugs causing reduction generic profit rate historically effect trend generic profitability mitigated efforts negotiate reduced acquisition costs generic pharmaceuticals manufacturers however recent years significant consolidation within generic manufacturing industry possible dynamic may enhance ability manufacturers sustain increase pricing generic pharmaceuticals diminish ability negotiate reduced acquisition costs in addition past several years us health care industry subject increase governmental regulation federal state levels efforts control health care costs including prescription drug costs underway federal state government levels changing political economic regulatory influences may significantly affect health care financing reimbursement practices aca made several significant changes medicaid rebates reimbursement one changes revise definition amp reimbursement formula multi source ie generic drugs in addition aca made changes affect coverage plan designs provided many health plan clients including requirement health insurers meet minimum medical loss ratio avoid pay rebates enrollees these aca changes may affect business directly could indirectly impact services andor business practices the possibility pbm client loss andor failure win new pbm business our pbm business generates net revenues primarily contracting clients provide prescription drugs related health care services plan members pbm client contracts often terms approximately three years duration approximately one third pbms client base typically subject renewal year in cases however pbm clients may negotiate shorter longer contract term may require early periodic renegotiation pricing prior expiration contract in addition reputational impact service related incident could negatively affect ability grow retain client base further pbm industry impacted consolidation activity may continue future in event one pbm clients acquired entity also client may unable retain portion acquired business these circumstances either individually aggregate could result adverse effect business financial results therefore continually face challenges competing new pbm business retaining renewing existing pbm business there assurance able win new business secure renewal business terms favorable us present terms risks related frequency rate introduction generic drugs brand name prescription products the profitability business dependent upon utilization prescription drug products utilization trends affected among factors introduction new successful prescription pharmaceuticals well lower priced generic alternatives existing brand name products accordingly business could impacted slowdown introduction new successful prescription pharmaceuticals andor generic alternatives sale normally yield higher gross profit margins brand name equivalents risks relating market availability suppliers safety profiles ofprescription drugs purchase sell we dispense significant volumes brand name generic drugs retail mail order pharmacies pbm network retail pharmacies when increased safety risk profiles manufacturing supply issues specific drugs classes drugsoccur drugs become subject greater restrictions controlled substances physicians may cease writingprescriptions drugs theutilization drugs may otherwise reducedadditionallyadverse publicity regarding drugs higher safety risk profiles may result reduced consumer demand drugs on occasion products withdrawn manufacturers transition counter products result lower prescription utilizationin addition future fda rulings could restrict supply increase cost products sold customers our volumes net revenues profitability cash flows may decline result regulatory rulings market changes risks declining gross margins pbm industry the pbm industry experiencing margin pressure result competitive pressures increased client demands lower prices enhanced service offerings andor higher service levels in regard maintain contractual relationships generic pharmaceutical manufacturers brand name pharmaceutical manufacturers provide purchase discounts andor rebates drugs dispensed pharmacies retail network mail order pharmacies portion may passed clients manufacturer rebates often depend pbms ability meet contractual market share requirements including cases placement manufacturers products pbms formularies if lose relationship one pharmaceutical manufacturers discounts rebates provided pharmaceutical manufacturers decline business financial results could adversely affected further competitive pressures pbm industry caused pbm pbms share clients larger portion rebates andor discounts received pharmaceutical manufacturers in addition market dynamics regulatory changes impacted ability offer plan sponsors pricing includes use retail differential spread could negatively impact future profitability further changes existing federal state laws regulations adoption new laws regulations relating patent term extensions purchase discount rebate arrangements pharmaceutical manufacturers formulary management pbm services could also reduce discounts rebates receive our retail pharmacy segment also impacted margin pressures described regulatory business changes relating participation medicare partd since inception medicare partd resulted increased utilization decreased pharmacy gross margin rates higher margin business cash state medicaid customers migrated medicare partd coverage further result aca changes medicare partd elimination tax deductibility retiree drug subsidy payment received sponsors retiree drug plans pbm clients could decide discontinue providing prescription drug benefits medicare eligible members to extent occurs adverse effects increasing customer migration medicare partd may outweigh benefits realize growth medicare partd business in addition cost complexity medicare partd exceed managements expectations prevent effective program implementation administration changes regulations regarding drug costs reported medicare partd retiree drug subsidy purposes implemented manner impacts profitability medicare partd business government alters medicare program requirements reduces funding higher anticipated cost taxpayers medicare partd reasons fail design maintain programs attractive medicare participants cms imposes restrictions medicare partd business result audits regulatory actions fail successfully implement corrective action remedial measures sufficient prevent remove applicable restrictions may imposed cms fail effectively integrate operate medicare partd businesses acquired successful retaining enrollees winning contract renewals new contracts medicare partds competitive bidding process medicare partd services ability expand medicare partd services could impacted possible changes industry pricing benchmarks it possible pharmaceutical industry regulators may evaluate andor develop alternative pricing reference replace awp pricing reference used many pbm client contracts pharmaceutical purchase agreements retail network contracts specialty payor agreements contracts third party payors future changes use awp published pricing benchmarks used establish pharmaceutical pricing including changes basis calculating reimbursement federal state health programs andor payors could impact reimbursement receive medicare medicaid programs reimbursement receive pbm clients payors andor ability negotiate rebates andor discounts pharmaceutical manufacturers wholesalers pbms retail pharmacies the effect possible changes business cannot predicted time an extremely competitive business environment each retail pharmacy business pharmacy services business currently operates highly competitive evolving health care environment our competitive success impacted ability retail pharmacy business establish maintain contractual relationships pbms payors acceptable terms ability pharmacy services business establish maintain contractual relationships network pharmacies environment pbm clients considering adopting narrow restricted retail pharmacy networks as pharmacy retailer compete drugstore chains supermarkets discount retailers independent pharmacies membership clubsinternet companies retail health clinics well mail order pharmacies pbmsin regard many pharmacy benefit plans implemented plan designs mandate provide incentives fill maintenance medications mail order pharmacies to extent trend continues negative impact retail pharmacy could weigh increase mail order business andor increase participation maintenance choice program in addition competitors may offer services pricing terms may willing able offer competition may also come sources future competitors pbm industry eg express scripts optumrx catamaran prime therapeutics include large national pbm companies pbms owned large national health plans smaller standalone pbmssome competitors may offer services pricing terms may willing able offer in addition competition may also come sources future unless demonstrate enhanced value clients innovative product service offerings particularly rapidly changing industry may unable remain competitive in addition changes overall composition pharmacy networks reduced pharmacy access networks could adversely affect claims volume andor competitiveness generally relationship retail customers demand products services the success retail business depends part customer loyalty superior customer service ability persuade customers purchase products additional categories proprietary brands failure timely identify effectively respond changing consumer preferences spending patterns inability expand products purchased customers failure inability obtain offer particular categories products could negatively affect relationship customers demand products services reform us health care system congressional efforts reform us health care system finally came fruition passage aca resulting significant structural changes health insurance system see business government regulation many structural changes enacted aca implemented applicable regulations sub regulatory guidance yet issued andor finalized therefore remains considerable uncertainty full impact aca business while reforms may affect business directly affect coverage plan designs provided many health plan clients as result could indirectly impact many services business practices we cannot predict effect aca changes may retail pharmacy pharmacy services businesses possible legislative market driven changes health care system cannot anticipate could also occur the failure disruption information technology systems information security systems infrastructure support business protect privacy security sensitive customer business information many aspects operations dependent information systems information collected processed stored handled systems throughout operations receive retain transmit certain confidential information including personally identifiable information customers clients provide purchase products services enroll programs services register websites interact personnel otherwise communicate us in addition operations depend part secure transmission confidential information public networks our information systems subject damage interruption power outages computer telecommunications failures computer viruses security breaches including credit card information breaches vandalism catastrophic events human error although deploy layered approach address information security threats vulnerabilities including ones cybersecurity standpoint designed protect confidential information data security breaches compromise information security controls businesses interact results confidential information accessed obtained damaged used unauthorized improper persons could harm reputation expose us regulatory actions claims customers clients financial institutions payment card associations persons could adversely affect business financial position results operations moreover data security breach could require expend significant resources related information systems infrastructure could distract management key personnel performing primary operational duties if information systems damaged fail work properly otherwise become unavailable unable successfully complete planned consolidation pbm claims adjudication platforms may incur substantial costs repair replace may experience loss critical information customer disruption interruptions delays ability perform essential functions implement new innovative services in addition compliance changes privacy information security laws standards may result considerable expense due increased investment technology development new operational processes risks related compliance broad complex regulatory framework our business subject numerous federal state local laws regulations see business government regulation changes regulations may require extensive system operating changes may difficult implement untimely compliance noncompliance applicable laws regulations could adversely affect continued operation business including limited imposition civil criminal penalties suspension disgorgement payments government programs loss required government certifications approvals loss authorizations participate exclusion government reimbursement programs medicare medicaid programs loss registrations licensure the regulations subject include limited laws regulations described government regulation section accounting standards securities laws regulations tax laws regulations laws regulations relating protection environment health safety matters including governing exposure management disposal hazardous materials wastes regulations fda ftc fcc dea consumer product safety commission well state regulatory authorities governing sale advertisement promotion products sell in addition business interests outside united states subject foreign corrupt practices act applicable domestic international laws regulations we also subject terms various government agreements mandates including described government regulation section in regard business financial position results operations could affected existing new government legislative regulatory action including without limitation one following federal state laws regulations governing purchase distribution tracking management dispensing reimbursement prescription drugs related services whether retail mail applicable registration licensing requirements effect expiration patents covering brand name drugs introduction generic products frequency rate approvals fda new brand name generic drugs counter status brand name drugs fda regulation affecting retail pbm industry consumer protection laws affecting health care services loyalty programs products sell informational calls make andor marketing goods services rulesand regulations issued pursuant hipaa hitech act federal state laws affecting collection use disclosure transmission health personal information federal laws information privacy precipitated concerns information collection internet state security breach laws state laws limiting use disclosure prescriber information administration medicare partd including legislative changes andor cms rulemaking interpretation government regulation development administration review updating formularies drug lists federal state local waste management laws regulations applicable business including management pharmaceutical wastes photo processing solutions well storage transportation hazardous materials state laws regulations establishing changing prompt payment requirements payments retail pharmacies impact network access legislation regulations including willing provider laws ability manage pharmacy networks health care reform managed care reform plan design legislation insurance licensing insurance regulatory requirements applicable offering medicare partd programs services health care services direct regulation pharmacies pbms regulatory quasi regulatory bodies risks related litigation legal proceedings pharmacy services retail pharmacy highly regulated litigious industries we currently subject various litigation matters investigations audits government inquiries regulatory legal proceedings litigation particularly securities collective class action litigation often expensive disruptive we cannot predict outcome matters costs incurred may substantial regardless outcome our business financial condition results operations may adversely affected may required materially change business practices result proceedings we refer item legal proceedings additional information the foregoing comprehensive listing possible risks assurance correctly identified appropriately assessed factors affecting business as refer managements discussion analysis financial condition results operations includes cautionary statement concerning forward looking statements end section annual report stockholders year ended december section incorporated reference itemb unresolved staff comments there unresolved sec staff comments item properties we lease stores long term leases vary rental amounts expiration dates renewal options rental provisions for additional information amount rental obligations leases refer note leases annual report stockholders year ended december section incorporated reference herein as december owned approximately retail stores net selling space retail drugstores increased million square feet december more one third store base opened significantly remodeled within last five years we ten distribution centers located alabama california hawaii new york rhode island south carolina tennessee texas lease ten additional distribution facilities located arizona floridaindiana michigan new jersey pennsylvania texas virginia brazil the distribution centers total approximately million square feet december as december owned one mail service dispensing pharmacy located texas leased three additional mail service dispensing pharmacies located hawaiiillinois pennsylvania we leased call centers located missouri pennsylvania tennessee texas as december leased onsite pharmacy stores specialty pharmacy stores operated specialty mail order pharmacies one owned we corporate offices located woonsocket rhode island totals approximately square feet in addition lease large corporate offices scottsdale arizona northbrookillinois irving texas sao paulo brazil in connection certain business dispositions completed continue guarantee lease obligations approximately former stores we indemnified guarantee obligations respective purchasers these guarantees generally remain effect initial lease term extension thereof pursuant renewal option provided lease prior time disposition for additional information refer note commitmentsand contingencies annual report stockholders year ended december section incorporated reference herein management believes owned leased facilities suitable adequate meet companys anticipated needs at end existing lease terms management believes leases renewed replaced alternate space the following breakdown state district columbia puerto rico brazil retail stores onsite pharmacy stores specialty pharmacy stores specialty mail order pharmacies mail service dispensing pharmacies december retailstores onsite pharmacy stores specialty pharmacy stores specialty mailorder pharmacies mail service dispensing pharmacies total united states alabama arkansas arizona california colorado connecticut delaware district columbia florida georgia hawaii iowa illinois indiana kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina tennessee texas utah vermont virginia washington west virginia wisconsin total united states brazil total item legal proceedings ilegal proceedings caremark term caremark used herein generally refer one pbm subsidiaries company applicable defendant qui tam lawsuit initially filed relator behalf various state federal government agencies texas federal court the case unsealed may the case sought monetary damages alleged caremarks processing medicaid certain government claims behalf clients allegedly resulted underpayments caremark clients applicable government agencies one caremarks adjudication platforms violated applicable federal state false claims acts fraud statutes the united states states texas tennessee florida arkansas louisiana california intervened lawsuit tennessee florida withdrew lawsuit august may respectively thereafter company prevailed several motions partial summary judgment following appellate ruling fifth circuit court appeals affirmed part reversed part prior rulings claims asserted case caremark substantially narrowed in december case dismissed following settlement company plaintiffs in related matter december company received document subpoena office inspector general oig within us department health human services hhs requesting information relating processing medicaid government agency claims different adjudication platform caremark the company provided documents information response request information the company conducting discussions united states department justice doj oig regarding possible settlement legal matter caremark named putative class action lawsuit filed october alabama state court john lauriello purportedly behalf participants settlement various securities class action derivative lawsuits caremark others other defendants include insurance companies provided coverage caremark respect settled lawsuits the lauriello lawsuit seeks approximately billion compensatory damages plus non specified damages based allegations amount insurance coverage available settled lawsuits misrepresented suppressed similar lawsuit filed november frank mcarthur also alabama state court naming defendants among others caremark several insurance companies involved settlement this lawsuit stayed later filed class action mcarthur subsequently allowed intervene lauriello action following close class discovery trial court entered order august granted plaintiffs motion certify class pursuant alabama ruleof civil procedures denied request class also certified pursuant ruleb in addition august order appointed class representatives class counsel the defendants appeal plaintiffs cross appeal pending alabama supreme court the proceedings trial court stayed statute pending decision appeal cross appeal alabama supreme court various lawsuits filed alleging caremark violated applicable antitrust laws establishing maintaining retail pharmacy networks client health plans in august bellevue drug co robert schreiberinc dba burns pharmacy rehn huerbinger drug co dba parkway drugs together pharmacy freedom fund national community pharmacists association filed putative class action caremark pennsylvania federal court seeking treble damages injunctive relief this case initially sent arbitration based contract terms pharmacies caremarkin october two independent pharmacies north jackson pharmacyinc ccinc dba big discount drugsinc filed putative class action complaint alabama federal court caremark two pbm competitors seeking treble damages injunctive relief the north jackson pharmacy case two caremark entities named defendants transferred illinois federal court case separate caremark entity sent arbitration based contract terms pharmacies caremark the bellevue arbitration stayed parties pending developments north jackson pharmacy court case in august bellevue case north jackson pharmacy case transferred pennsylvania federal court judicial panel multidistrict litigation coordinated consolidated proceedings cases panel including cases pbmscaremark appealed decision vacated order compelling arbitration staying proceedings bellevue case following appeal court appeals reinstated order compelling arbitration bellevue case following remand plaintiffs bellevue case sought dismissal complaint permit immediate appeal reinstated order compelling arbitration pursued appeal third circuit court appeals in november third circuit court reversed district court ruling directed parties proceed federal court motions class certification coordinated cases within multidistrict litigation including north jackson pharmacy case remain pending court permitted certain additional class discovery briefing the consolidated action known in re pharmacy benefit managers antitrust litigation in november securities class action lawsuit filed united states district court district rhode island purportedly behalf purchasers cvs caremark corporation stock may november plaintiffs subsequently amended lawsuit allege class period beginning october the lawsuit names company certain officers defendants includes allegations securities fraud relating public disclosures made company concerning pbm business allegations insider trading in addition shareholder derivative lawsuit filed december court directors certain officers company this lawsuit stayed pending developments related securities class action includes allegations among things securities fraud insider trading breach fiduciary duties alleges company damaged purchase stock allegedly inflated prices share repurchase program in january lawsuits transferred united states district court district new hampshire in june court granted companys motion dismiss securities class action the plaintiffs subsequently appealed courts ruling motion dismiss in may first circuit court appeals vacated prior ruling remanded case district court proceedings in december district court denied company renewed motion dismiss lawsuit the derivative lawsuit remain stayed company answers securities class action complaint in march company learned various state attorneys general offices certain government agencies conducting multi state investigation certain company business practices similar investigated time us federal trade commission ftc twenty eight states district columbia county los angeles known participating investigation the prior ftc investigation commenced august officially concluded may consent order entered ftc company became final the company cooperated multi state investigation in march company received subpoena oig requesting information programs company offered customers remuneration conditioned upon transfer prescriptions drugs medications company pharmacies form gift cards cash non prescription merchandise discounts coupons non prescription merchandise the subpoena relates investigation possible false otherwise improper claims payment medicare medicaid programs the company provided documents information response request information the company received subpoena us securities exchange commission sec february subsequently received additional subpoenas requests information the secs requests related among things public disclosures made company transactions companys securities certain officers employees company purchase accounting longs drug stores acquisition the company provided documents information requested sec cooperating sec investigation the company reached agreement principle staff boston regional office sec settle certain allegations third fourth quarters company violated certain provisions securities act securities exchange act including certain anti fraud provisions statutes the agreement principle entered company admit deny basis company restating financial statements reporting period the company agreed pay million civil penalty settlement finalized amount fully reserved company financial statements the company continue cooperate sec document settlement terms settlement remains subject approval commission federal court required in january united states district court eastern district pennsylvania unsealed first amended qui tam complaint filed august individual relator described complaint employed firm providing pharmacy prescription benefit audit recovery services the complaint seeks monetary damages alleges caremark processing medicare claims behalf one clients violated federal false claims act the united states acting us attorney office philadelphia pennsylvania declined intervene lawsuit caremark filed motion dismiss amended complaint doj filed statement interest regard caremarks motion dismiss in december court denied caremark motion dismiss amended complaint in january company received subpoena oig requesting information health savings pass program prescription drug discount program uninsured underinsured individuals connection investigation possible false otherwise improper claims payment involving hhs programs in february company also received civil investigative demand office attorney general state texas requesting copy information produced oig subpoena information related prescription drug claims submitted companys pharmacies texas medicaid reimbursement the company providing documents information response requests information purported shareholder derivative action filed behalf nominal defendant cvs caremark corporation certain companys officers members board directors the action alleged single claim breach fiduciary duty relating company alleged failure properly implement internal regulatory controls comply controlled substances act combat methamphetamine epidemic act originally filed june in addition amended complaint filed november supplemental complaint filed april in october court granted companys motion dismiss entered judgment dismissing action without prejudice following dismissal action purported shareholder sent letter companys board directors demanding board investigate allegations pursue legal action certain directors officers company committee board directors conducting review intends respond letter appropriate in november company received subpoena oig requesting information concerning automatic refill programs used pharmacies refill prescriptions customers the company cooperating providing documents information response request information the company also party legal proceedings inquiries audits arising normal course business none expected material company we give assurance however business financial condition results operations materially adversely affected required materially change business practices based ifuture enactment new health care laws regulations iithe interpretation application existing laws regulations including laws regulations described business government regulation may relate business pharmacy services retail pharmacy retail clinic industry health care industry generally iiipending future federal state governmental investigations business pharmacy services retail pharmacy retail clinic industry health care industry generally ivinstitution government enforcement actions us vadverse developments pending qui tam lawsuit us whether sealed unsealed future qui tam lawsuit may filed us viadverse developments pending future legal proceedings us affecting pharmacy services retail pharmacy retail clinic industry health care industry generally iienvironmental matters item sec regulation requires disclosure certain environmental legal proceedings management reasonably believes proceedings involve potential monetary sanctions on january settlement agreement signed state new jersey resolve claims alleged noncompliance hazardous medical waste regulations connection certain companys facilities new jersey as part settlement company agreed pay civil penalties resolve claims item mine safety disclosures not applicable executive officers registrant executive officers registrant the following sets forth name age biographical information executive officers february in case officers term office extends date board directors meeting following next annual meeting stockholders company previous positions responsibilities held executive officers past five years indicated lisa bisaccia age senior vice president chief human resources officer cvs caremark corporation since january vice president human resources cvs pharmacyinc september december eva boratto age senior vice president controller chief accounting officer cvs caremark corporation since july senior vice president pbm finance july june vice president us market finance leader merck co inc merck june june vice president investor relations merck april may troyen brennan md age executive vice president chief medical officer cvs caremark corporation since november executive vice president chief medical officer aetnainc february november david denton age executive vice president chief financial officer cvs caremark corporation since january senior vice president controllerchief accounting officer cvs caremark corporation march december senior vice president financial administration cvs caremark corporation cvs pharmacyinc april march helena foulkes age executive vice president cvs caremark corporation president cvspharmacy since january executive vice president chief health care strategy marketing officer cvs caremark corporation march december executive vice president chief marketing officer cvs caremark corporation january february senior vice president health services cvs caremark corporation may january cvs pharmacyinc october january stephen gold age senior vice president chief information officer cvs caremark corporation since july senior vice president chief information officer avayainc may june executive vice president chief information officer chief technology officer gsi commerceinc february april david joyner age executive vice president cvs caremark corporation since march executive vice president sales account services cvs caremark pharmacy services since march per gh lofberg age executive vice president cvs caremark corporation executive vice president cvs caremark corporation president cvs caremark pharmacy services january august president chief executive officer generation healthinc pharmacogenomics company november december larry merlo age president chief executive officer cvs caremark corporation since march president chief operating officer cvs caremark corporation may march president cvspharmacy january august executive vice president cvs caremark corporation january may also director cvs caremark corporation since may thomas moriarty age executive vice president general counsel cvs caremark corporation since october general counsel celgene corporation global biopharmaceutical company may september general counsel corporate secretary medco health solutionsinc medco pharmacy benefit management company march april also president global pharmaceutical strategies medco march april senior vice president pharmaceutical strategies solutions medco september march jonathan roberts age executive vice president cvs caremark corporation president cvs caremark pharmacy services since september executive vice president cvs caremark corporation chief operating officer cvs caremark pharmacy services october august executive vice president rx purchasing pricing network relations cvs caremark corporation january october senior vice president chief information officer cvs caremark corporation may january cvs pharmacyinc january january andrew sussman md age senior vice president associate chief medical officer cvs caremark corporation since march president minuteclinic llc companys retail based health clinic subsidiary since september executive vice president chief operating officer university massachusetts memorial medical center major teaching affiliate umass medical school may august partii item market registrants common equity related stockholder matters issuer purchases equity securities our common stock listed new york stock exchange symbol cvs the table sets forth high low sale prices common stock new york stock exchange composite tape quarterly cash dividends declared per share common stock periods indicated firstquarter secondquarter thirdquarter fourthquarter year high low cash dividends per common share high low cash dividends per common share cvs caremark paid cash dividends every quarter since becoming public company future dividend payments depend companys earnings capital requirements financial condition factors considered relevant companys board directors as february registered shareholders according records maintained transfer agent on december companys board directors authorized new share repurchase program billion outstanding common stock repurchase program on september companys board directors authorized share repurchase program billion outstanding common stock repurchase program together repurchase program repurchase programs the repurchase programs effective immediately permit company effect repurchases time time combination open market repurchases privately negotiated transactions accelerated share repurchase transactions andor derivative transactions the repurchase programs may modified terminated board directors time pursuant authorization repurchase program effective october entered billion fixed dollar accelerated share repurchase asr agreement barclays bank plc barclays upon payment billion purchase price october received number shares common stock equal billion notional amount asr agreement approximately million shares price per share the company received approximately million shares common stock december average price per share representing remaining billion notional amount asr agreement thereby concluding agreement the total million shares common stock delivered company barclays term october asr agreement placed treasury stock during year ended december company repurchased aggregate million shares common stock approximately billion repurchase program as december remained aggregate approximately billion available future repurchases repurchase programs fiscalperiod totalnumber ofshares purchased average pricepaidper share totalnumberofshares purchasedaspartof publiclyannounced plansorprograms approximatedollar valueofsharesthat mayyetbe purchasedunderthe plansorprograms october october november november december december item selected financial data the selected consolidated financial data cvs caremark corporation periods indicated five year period ended december derived consolidated financial statements cvs caremark corporation the selected consolidated financial data read conjunction consolidated financial statements audit reports ernst young llp incorporated elsewhere herein inmillionsexceptpershareamounts statement operations data net revenues gross profit operating expenses operating profit interest expense net loss early extinguishment debt income tax provision income continuing operations income loss discontinued operations net tax net income net loss attributable noncontrolling interest net income attributable cvs caremark per common share data basic earnings per common share income continuing operations attributable cvs caremark loss discontinued operations attributable cvs caremark net income attributable cvs caremark diluted earnings per common share income continuing operations attributable cvs caremark loss discontinued operations attributable cvs caremark net income attributable cvs caremark cash dividends per common share balance sheet data total assets long term debt total shareholders equity number stores end year see note significant accounting policies revenue recognition retail pharmacy segment consolidated financial statements income tax provision includes effect following iin recognition million previously unrecognized tax benefits including interest relating expiration various statutes limitation settlements tax authorities iiin recognition million previously unrecognized tax benefits including interest relating expiration various statutes limitation settlements tax authorities as discussed note consolidated financial statements results theracom business presented discontinued operations excluded continuing operations periods presented in connection certain business dispositions completed company retained guarantees store lease obligations number former subsidiaries including linens things filed bankruptcy the companys income loss discontinued operations includes lease related costs company believes likely required satisfy pursuant linens things lease guarantees below summary results discontinued operations year ended december inmillions income operations theracom gain disposal theracom loss disposal linens things income tax benefit provision income loss discontinued operations net tax represents minority shareholders portion net loss majority owned subsidiary generation healthinc acquired fourth quarter in june company acquired remaining interest generation healthinc minority shareholders employee option holders effective january company changed methods accounting prescription drug inventories retail pharmacy segment additional details accounting change discussed note consolidated financial statements item managements discussion analysis financial condition results operations we refer managements discussion analysis financial condition results operations includes cautionary statement concerning forward looking statements end section annual report stockholders year ended december section incorporated reference herein itema quantitative qualitative disclosures market risk as december company derivative financial instruments derivative commodity instruments place believes exposure market risk associated financial instruments principally interest rate risk inherent debt portfolio material item financial statements supplementary data we refer consolidated statements income consolidated statements comprehensive income consolidated balance sheets consolidated statements shareholders equity consolidated statements cash flows notes consolidated financial statements report independent registered public accounting firm annual report stockholders fiscal year ended december sections incorporated reference herein item changes disagreements accountants accounting financial disclosure none itema controls procedures evaluation disclosure controls procedures the companys chief executive officer chief financial officer evaluating effectiveness design operation companys disclosure controls procedures defined exchange act rulesa fand december concluded date companys disclosure controls procedures adequate effective reasonable assurance level designed ensure material information relating company subsidiaries would made known officers timely basis internal control financial reporting we refer managements report internal control over financial reporting report independent registered public accounting firm annual report stockholders fiscal year ended december incorporated reference herein managements report registrants internal control financial reporting independent registered public accounting firms report respect effectiveness internal control financial reporting changes internal control financial reporting there changes internal controls financial reporting identified connection evaluation required paragraph dof rulea ruled occurred fourth quarter ended december materially affected reasonably likely materially affect internal control financial reporting itemb other information no events occurred fourth quarter would require disclosure item partiii item directors executive officers corporate governance we refer proxy statement annual meeting stockholders captions committees board code conduct director nominations audit committee report biographies board nominees sectionabeneficial ownership reporting compliance sections incorporated reference herein biographical information executive officers contained parti annual report form item executive compensation we refer proxy statement annual meeting stockholders captions executive compensation related matters including compensation discussion analysis management planning development committee report sections incorporated reference herein item security ownership certain beneficial owners management related stockholder matters we refer proxy statement annual meeting stockholders captions share ownership directors certain executive officers share ownership principal stockholders sections incorporated reference herein information concerning security ownership certain beneficial owners management related stockholder matters the following table summarizes information companys common stock may issued upon exercise options warrants rights equity compensation plans december numberof securitiestobe issuedupon exerciseof outstanding optionswarrants andrights weighted averageexercise priceof outstanding optionswarrants andrights numberofsecurities remainingavailablefor futureissuanceunder equitycompensation plansexcluding securitiesreflectedin firstcolumn equity compensation plans approved stockholders equity compensation plans approved stockholders total shares thousands item certain relationships related transactions director independence we refer proxy statement annual meeting stockholders caption independence determinations directors certain transactions directors officers sections incorporated reference herein item principal accountant fees services we refer proxy statement annual meeting stockholders caption item ratification appointment independent registered public accounting firm section incorporated reference herein partiv item exhibits financial statement schedules documents filed part report financial statements the following financial statements incorporated reference annual report stockholders fiscal year ended december provided item hereof consolidated statements income years ended december consolidated statements comprehensive income years ended december consolidated balance sheets december consolidated statements cash flows years ended december consolidated statements shareholders equity years ended december notes consolidated financial statements report independent registered public accounting firm financial statement schedules all financial statement schedules omitted applicable required instructions information included consolidated financial statements related notes exhibits exhibits marked asterisk hereby incorporated reference exhibits appendices previously filed registrant indicated brackets following description exhibit exhibit description agreement plan merger dated november among registrant caremark rxinc twain mergersub corp incorporated reference exhibit registrants registration statement no forms filed december amendment no dated january agreement plan merger dated november among registrant caremark rxinc twain merger sub corp incorporated reference exhibit registrants registration statement no forms filed january waiver agreement dated january registrant caremark rxinc respect agreement plan merger dated november registrant caremark rxinc incorporated reference exhibit registrants registration statement no forms filed january amendment waiver agreement dated february registrant caremark rxinc incorporated reference exhibit registrants current report form dated february commission file no amendment waiver agreement dated march registrant caremark rxinc incorporated reference exhibit registrants current report form dated march commission file no agreement plan merger dated august among registrant longs drug stores corporation blue mergersub corp incorporated reference exhibit registrants current report form dated august commission file no amended restated certificate incorporation registrant incorporated reference exhibit registrants annual report form fiscal year ended december commission file no certificate amendment amended restated certificate incorporation effective may incorporated reference exhibita registrants registration statement no forms dated may certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report form dated march commission file no certificate merger dated may incorporated reference exhibitc registrants quarterly report form dated november commission file no certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report form dated may commission file no certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report on form dated may commission file no by laws registrant amended restated incorporated reference exhibit registrants current report form dated january commission file no pursuant regulation kitem biiia instrument defines rights holders long term debt registrant subsidiaries filed report the registrant hereby agrees furnish copy instrument securities exchange commission upon request specimen common stock certificate incorporated reference exhibit registration statement registrant form dated november commission file no stock purchase agreement dated october the tjx companiesinc melville corporation amended november incorporated reference exhibits melvilles current report form dated december commission file no stock purchase agreement dated march melville corporation consolidated stores corporation amended may incorporated reference exhibits melvilles current report form dated may commission file no distribution agreement dated september among melville corporation footstarinc footstar centerinc incorporated reference exhibit melvilles current report form dated october commission file no tax disaffiliation agreement dated september among melville corporation footstarinc certain subsidiaries named therein incorporated reference exhibit melvilles current report form dated october commission file no stockholder agreement dated december registrant nashua hollis cvsinc linens thingsinc incorporated reference exhibitito registrants annual report form fiscal year ended december commission file no tax disaffiliation agreement dated december registrant linens thingsinc certain respective affiliates incorporated reference exhibitito registrants annual report form fiscal year ended december commission file no four year credit agreement dated may among registrant lenders party thereto barclays capital jp morgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form fiscal quarter ended june commission file no amendment no dated november credit agreement dated may among registrant lenders party thereto co syndication agents co documentation agents named therein the bank new york mellon administrative agent incorporated reference exhibit registrants annual report form fiscal year ended december commission file no five year credit agreement dated february among registrant lenders party thereto barclays capital jpmorgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents the bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form fiscal quarter ended march commission file no credit agreement dated may among registrant lenders party thereto barclays bank plc jpmorgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents the bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form fiscal quarter ended june commission file no amendment no dated may credit agreement dated may among registrant lenders party thereto barclays capital jpmorgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents the bank america na wells fargo bank na co documentation agents the bank bank new york mellon administrative agent previously amended amendment no dated november incorporated reference exhibit registrants quarterly report form fiscal quarter ended june commission file no supplemental retirement plan select senior management cvs caremark corporation amended restated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no cvs caremark corporation directors stock plan amended restated november incorporated reference exhibit registrants annual report form fiscal year ended december commission file no incentive compensation plan amended december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no caremark rxinc incentive stock plan incorporated reference exhibit registrants registration statement no forms filed march cvs caremark deferred stock compensation plan amended restated incorporated reference exhibit registrants quarterly report form quarter ended june commission file no cvs caremark deferred compensation plan amended restated incentive compensation plan amended january incorporated reference exhibit registrant annual report form fiscal year ended december commission file no employee stock purchase plan incorporated reference exhibitd registrants definitive proxy statement filed april commission file no the registrants management incentive plan the registrants long term incentive plan the registrants partnership equity program amended august the registrants severance plan non store employees amended april the registrants performance based restricted stock unit plan amended april form enterprise non competition non disclosure developments agreement registrant certain registrants executive officers universal definition document dated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no formof non qualified stock option agreement registrant selected employees registrant formof restricted stock unit agreement annual grant registrant selected employees registrant formof performance based restricted stock unit agreement registrant selected employees registrant formof partnership equity program participant purchased rsus company matching rsus company matching options agreement pre tax formof partnership equity program participant purchased rsus company matching rsus company matching options agreement post tax amended restated employment agreement dated december registrant registrants president chief executive officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no amendment dated december amended restated employment agreement dated december registrant registrants president chief executive officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no formof non qualified stock option agreement registrant registrants president chief executive officer formof restricted stock unit agreement registrant registrants president chief executive officer change control agreement dated december registrant registrants executive vice president chief financial officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no amendment dated december change control agreement dated december registrant registrants executive vice president chief financial officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no change control agreement dated december registrant registrants executive vice president president cvs caremark pharmacy services incorporated reference exhibit registrants annual report form fiscal year ended december commission file no amendment dated december change control agreement dated december registrant registrants executive vice president president cvs caremark pharmacy services incorporated reference exhibit registrants annual report form fiscal year ended december commission file no letter agreement dated august registrant registrants former executive vice president president cvspharmacy incorporated reference exhibit registrants annual report form fiscal year ended december commission file no change control agreement dated september registrant registrants former executive vice president president cvspharmacy incorporated reference exhibit registrants annual report form fiscal year ended december commission file no separation agreement registrant registrants former executive vice president president cvspharmacy dated december change control agreement dated december registrant registrants former executive vice president chief medical officer portions annual report stockholders cvs caremark corporation specifically designated form incorporated reference subsidiaries registrant consent ernst young llp certification chief executive officer pursuant section sarbanes oxley act certification chief financial officer pursuant section sarbanes oxley act certification chief executive officer pursuant section sarbanes oxley act certification chief financial officer pursuant section sarbanes oxley act the following materials cvs caremark corporation annual report form year ended december formatted extensible business reporting language xbrl ithe consolidated statements income iithe consolidated balance sheets iiithe consolidated statements cash flows ivrelated notes signatures pursuant requirements section dof securities exchange act registrant duly caused annual report form signed behalf undersigned thereunto duly authorized cvs caremark corporation date february by sdavid denton david denton executive vice president chief financial officer pursuant requirements securities exchange act report signed following persons behalf registrant capacities dates indicated signature titles date sc david brown ii director february david brown ii eva boratto senior vice president finance controller principal accounting officer february eva boratto sdavid denton executive vice president chief financial officer principal financial officer february david denton nancy ann deparle director february nancy ann deparle sdavid dorman chairman board director february david dorman sanne finucane director february anne finucane slarry merlo president chief executive officer principal executive officer director february larry merlo sjean pierre millon director february jean pierre millon srichard swift director february richard swift swilliam weldon director february william weldon stony white director february tony white